| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/27/2006 | US20060088598 Intravenous composition, process for producing the same and preparation thereof |
| 04/27/2006 | US20060088573 Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088552 Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor |
| 04/27/2006 | US20060088545 Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/27/2006 | US20060088520 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | CA2584485A1 Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| 04/27/2006 | CA2584398A1 Ester derivative and pharmaceutical use thereof |
| 04/27/2006 | CA2584262A1 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | CA2584248A1 Methods of treating vascular injuries |
| 04/27/2006 | CA2584048A1 Multi-domain amphipathic helical peptides and methods of their use |
| 04/27/2006 | CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583710A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2583565A1 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease causedby necrosis or apoptosis |
| 04/27/2006 | CA2583185A1 Use of a2a adenosine receptor agonists |
| 04/27/2006 | CA2583153A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | CA2581723A1 Process for preparing telmisartan |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1650206A1 Phenylazole compounds, production process, and antioxidants |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1649872A1 Sheet for guiding regeneration of mesenchymal tissue and production method thereof |
| 04/26/2006 | EP1649863A1 Composition for lowering serum uric acid level |
| 04/26/2006 | EP1649854A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 04/26/2006 | EP1649853A2 Microtubule stabilizing agents for treating atherosclerosis or restenosis |
| 04/26/2006 | EP1649761A1 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves |
| 04/26/2006 | EP1648906A1 Organosilicon compounds and their use |
| 04/26/2006 | EP1648885A1 Novel compounds |
| 04/26/2006 | EP1648567A1 Perinatal hypoxic-ischemic brain damage treatment |
| 04/26/2006 | EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/26/2006 | EP1648515A1 Chlorthalidone combinations |
| 04/26/2006 | EP1648494A2 Novel anti-angiogenetic agent and its use, in particular in cancer treatment |
| 04/26/2006 | EP1648475A2 Use of nitrite salts for the treatment of cardiovascular conditions |
| 04/26/2006 | EP1648470A1 A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor |
| 04/26/2006 | EP1648456A1 Use of 3,7-diazabicyclo¬3,3,1|nonane compounds for the treatment and/or prophylaxis of arrhythmic events in male human patients |
| 04/26/2006 | EP1648450A1 Medicaments containing derivatives of aryl (or heteroaryl) azolylcarbinols |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648437A2 Sirt1 modulators for manipulating cell/organism lifespan/stress response |
| 04/26/2006 | EP1648431A1 Novel use of a polyamine-poor composition for the production of a medical human food |
| 04/26/2006 | EP1534708B1 Purine derivatives and their use as antiproliferative agents |
| 04/26/2006 | EP1465852A4 Synthesis of combretastatin a-2 prodrugs |
| 04/26/2006 | EP1448281A4 Therapeutic coating for an intravascular implant |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1361894B1 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke acting as a health protecting agent during smoking |
| 04/26/2006 | EP1320710B1 Drying method for selectively removing volatile components from wet coatings |
| 04/26/2006 | EP1294689B1 Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 04/26/2006 | EP1185666B1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764462A T-type calcium channel blockers |
| 04/26/2006 | CN1764456A Treatment of diseases with alpha-7nACh receptor full agonists |
| 04/26/2006 | CN1763214A Enzymatic synthesis method of 6-chloropurine riboside |
| 04/26/2006 | CN1763069A Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/26/2006 | CN1762471A Chinese medicine for treating arteriosclerosis |
| 04/26/2006 | CN1762470A Traditional Chinese medicine composition for treating coronary disease |
| 04/26/2006 | CN1762447A Production method of bulk drug for Szechuan pepper and kudzuvine root compound formulation |
| 04/26/2006 | CN1762442A Quick acting heart-benefiting hawthorn leaf ketone prepartion |
| 04/26/2006 | CN1762440A Medicine for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/26/2006 | CN1762438A Medicinal composition for treating dizziness with qi-deficiency blood-stasis pattern and preparing process thereof |
| 04/26/2006 | CN1762434A Compound formulation of breviscapine and asarum herb for treating cardiovascular and cerebrovascular diseases and its application |
| 04/26/2006 | CN1762430A Chinese medicine for treating cardiovascular diseases |
| 04/26/2006 | CN1762422A Process for preparing soft capsule of red sage root and notoginseng |
| 04/26/2006 | CN1762421A Pills for coronary insufficiency and its formula |
| 04/26/2006 | CN1762420A Pulse invigorating pill prescription and its preparation method |
| 04/26/2006 | CN1762417A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparation process and use |
| 04/26/2006 | CN1762410A Chinese dodder seed extract, its preparation method, Chinese proprietary medicine containing extracts thereof and use thereof |
| 04/26/2006 | CN1762409A Snakegourd peel lyophilized powder injection and its preparation process |
| 04/26/2006 | CN1762407A Method for preparing Chinese medicinal formulation to prevent and treat apoplexy |
| 04/26/2006 | CN1762406A Quality control method of ixeris sonchifolia injection |
| 04/26/2006 | CN1762403A Soft capsule of erigeron breviscapus effective component extracts and preparation method thereof |
| 04/26/2006 | CN1762402A Dispersible tablet of erigeron breviscapus effective component extracts and preparation method thereof |
| 04/26/2006 | CN1762400A 'Xuesaitong' formulation and its preparation method |
| 04/26/2006 | CN1762375A Erigeron breviscapus ketone ester and its injection preparation process |
| 04/26/2006 | CN1762373A 'Xueshuantong' soft capsule and its preparation |
| 04/26/2006 | CN1762372A 'Thrombus-removing' infusion liquid and its preparation method |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762362A Medicinal composition with red sage root component for treating cardiovascular and cerebrovascular disease and its application |
| 04/26/2006 | CN1762361A Pharmaceutical composition containing amiodipine besylate and rosuvastatin calcium, and its preparation method |
| 04/26/2006 | CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 04/26/2006 | CN1762354A Stable pharmaceutical composition containing calcium blocker |
| 04/26/2006 | CN1762353A Pharmaceutical composition containing amiodipine besylate and nisvastatin calcium and its preparation method |
| 04/26/2006 | CN1762343A EGCG-zinc complex solid dispersion, its preparation method and application |
| 04/26/2006 | CN1762342A Safflor yellow A-containing pharmaceutical composition, its preparation method and usage |
| 04/26/2006 | CN1762341A Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof |
| 04/26/2006 | CN1253569C Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |